6505--Trastuzumab and Biosimilars (VA-25-00052526) 36E79725R0038
Summary
AI-generated · Aug 24, 2025Solicitation for trastuzumab and biosimilars under a combined synopsis/solicitation VA-25-00052526.
Two awards are recorded, both with $0.00 amounts and no award dates shown. No additional changes or new information are provided in the available data, and no specific requirements (such as brand-name restrictions or site visits) are listed in the provided record.
Trastuzumab and Biosimilars (VA-25-00052526)
From Combined Synopsis/Solicitation posted on Jun 23, 2025Trastuzumab and Biosimilars (VA-25-00052526)
From Combined Synopsis/Solicitation posted on Jul 08, 2025Notice history
2-
Combined Synopsis/Solicitation Posted Jun 23, 2025
-
Combined Synopsis/Solicitation LATEST Posted Jul 08, 2025View changes (1)
- Response Deadline: Jul 08, 2025 → Jul 15, 2025
Details
Award Information
Contacts
Contract Specialist
Phone
Agency
Place of Performance
Hines, Illinois 60141
USA